Results 141 to 150 of about 18,295 (182)
Some of the next articles are maybe not open access.
Treatment of visceral leishmaniasis
Expert Opinion on Pharmacotherapy, 2005The Leishmania donovani complex includes L. chagasi and L. infantum, and causes visceral leishmaniasis (VL), a disseminated and potentially fatal form of leishmaniasis. The treatment options for VL are limited. Pentavalent antimonials (Sbv) are the first-line treatment options worldwide except for in Europe and Sbv-unresponsive regions of India ...
Shyam, Sundar, Madhukar, Rai
openaire +2 more sources
Visceral leishmaniasis in paediatrics
Current Opinion in Infectious Diseases, 2002Visceral leishmaniasis is a vector-borne systemic infection, which affects half a million people each year in many areas of the world. Typical disease manifests with fever, hepatosplenomegaly, pancytopenia, and progressive deterioration of the host. Although molecular methods appear promising as a non-invasive diagnostic tool, definite diagnosis still ...
Dimitris A, Kafetzis, Helen C, Maltezou
openaire +2 more sources
Mediterranean Visceral Leishmaniasis in Pregnancy
Scandinavian Journal of Infectious Diseases, 1994Visceral leishmaniasis (VL) in pregnancy is rare in Mediterranean countries. We report here 2 cases of VL in pregnant women who acquired the infection in Italy. In the first case, the disease was diagnosed and treated with liposomal amphotericin B during the pregnancy.
GRADONI L +4 more
openaire +3 more sources
MYELOFIBROSIS IN VISCERAL LEISHMANIASIS
British Journal of Haematology, 1991M, Saleem +4 more
openaire +2 more sources
Visceral leishmaniasis in Niger
Transactions of the Royal Society of Tropical Medicine and Hygiene, 1989Y, Gaultier +2 more
openaire +2 more sources